"The choice of SPAC was obvious to us"

  • Publication publiée :11 May 2022
  • Post category:Operation
You are currently viewing “Le choix du SPAC s’est imposé comme une évidence à nos yeux”

eureKING, the first European SPAC dedicated to biomanufacturing in the healthcare sector, completed on Tuesday a €150 million IPO on Euronext with professional investors. CEO and co-founder Michael Kloss explains to Finascope the motivations and timing of this operation in a complicated market context, the objectives targeted in this transaction and the...

Share this article